MoonLake Immunotherapeutics (MLTX) Free Cash Flow Growth (3y) (2024 - 2026)
MoonLake Immunotherapeutics (MLTX) Free Cash Flow Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 24.91% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 20.11% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 14.71% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | MoonLake Immunotherapeutics | 1.27 Bn | 910.04 Mn | - | -94.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94.39% |
| Dec 31, 2025 | -71.79% |
| Sep 30, 2025 | -68.25% |
| Jun 30, 2025 | -37.97% |
| Mar 31, 2025 | -39.04% |
| Dec 31, 2024 | -11.36% |
| Sep 30, 2024 | -132.17% |
| Jun 30, 2024 | -2.90% |
| Mar 31, 2024 | -420.04% |